Institution
Loma Linda University
Education•Loma Linda, California, United States•
About: Loma Linda University is a education organization based out in Loma Linda, California, United States. It is known for research contribution in the topics: Population & Medicine. The organization has 9220 authors who have published 13485 publications receiving 447094 citations. The organization is also known as: University of Loma Linda.
Topics: Population, Medicine, Poison control, Transplantation, Health care
Papers published on a yearly basis
Papers
More filters
TL;DR: The similar clinical and pathologic findings in these rapidly fatal tumors in infants and the demonstration of abnormalities of chromosome 22q11 in a majority of the cases supports their histogenetic and nosologic relationship to the family of malignant rhabdoid tumors that typically occur in young children in several anatomic sites, including kidney, soft tissues, liver, and brain.
Abstract: The clinical, pathologic, and immunohistochemical features of a widely disseminated tumor with rhabdoid phenotype are described in nine infants ≤3 months of age. Five neonates had tumor evident at birth, two of which had placental metastases. The average survival following diagnosis was <6 weeks. No
113 citations
TL;DR: Findings from this report point to the need for screening and assessment tools that are rigorously developed, clinically relevant, and adapted to a diversity of clinical and cultural settings.
112 citations
TL;DR: Examination of children's sleep difficulties and severity of autism along with mothers' sleep problems in relation to stress levels reported by mothers suggest including children'sSleep problems along with their symptomatic behavior when examining factors that contribute to stress in mothers of children with autism.
Abstract: Parenting a child with autism has been associated with maternal stress. The present investigation examined children's sleep difficulties and severity of autism along with mothers' sleep problems in...
112 citations
TL;DR: A novel biosynthetic pathway that leads to the formation of AT-NPD1 mediator in the brain was discovered and administration of synthetic AT- NPD1 was able to attenuate cerebral ischemic injury which leads to a novel approach for pharmaceutical intervention and clinical translation.
112 citations
112 citations
Authors
Showing all 9287 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Bruce L. Miller | 163 | 1153 | 115975 |
| Jonathan I. Epstein | 138 | 1121 | 80975 |
| Tony L. Yaksh | 123 | 806 | 60898 |
| David M. Livingston | 118 | 312 | 58142 |
| William B. Isaacs | 117 | 521 | 58187 |
| Alan W. Partin | 111 | 710 | 54213 |
| David N. Herndon | 108 | 1227 | 54888 |
| Edward R. Laws | 105 | 722 | 39822 |
| David C. Bellinger | 98 | 452 | 35449 |
| Pedram Argani | 97 | 372 | 35607 |
| Michael W. Steffes | 96 | 341 | 43260 |
| Gary K. Steinberg | 94 | 529 | 31259 |
| Michael S. Gazzaniga | 92 | 372 | 35305 |
| David J. Baylink | 90 | 425 | 29109 |
| Jesse B. Jupiter | 90 | 543 | 26480 |